BioSpace News Archive

Genetown

Blueprint Medicines’ AYVAKYT® (avapritinib) Receives Positive CHMP Opinion for the Treatment of Adults with Advanced Systemic Mastocytosis

Positive opinion based on results from two clinical trials that comprise the largest clinical trial dataset in advanced systemic mastocytosis.

January 28, 2022
·
10 min read
Genetown

ENVI Announces Quorum to Pass Business Combination With GreenLight Biosciences and Achievement of All Transaction Requirements Following the Redemption Deadline

Environmental Impact Acquisition Corporation (“ENVI” or the “Company”) (Nasdaq: ENVI) today announced that it had achieved a quorum for the special meeting of its shareholders to be held on February 1, 2022 (the “Special Meeting”), in connection with its business combination with GreenLight Biosciences Inc. (“GreenLight”), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture

January 28, 2022
·
8 min read
Business

CARRA Appoints Larry Hausner as Interim CEO

Childhood Arthritis and Rheumatology Research Alliance (CARRA) announced its appointment of Larry Hausner as interim chief executive officer, effective today.

January 28, 2022
·
2 min read
Global Point Of Care CT Imaging Market – Growth and Industry Analysis

The global point of care CT imaging market is foreseen to register promising growth trajectory during 2019–2029.

January 28, 2022
·
5 min read
Protein Therapeutics Market | Growth Analysis and Latest Trends

The protein therapeutics market has been anticipated to experience various growth opportunities in the years to come.

January 28, 2022
·
5 min read
Getinge Year End Report 2021: “Healthy order growth, improved EBITA margin and strong cash flow”

The organic order intake increased 6.4% in the fourth quarter following growth in all business areas and regions

January 28, 2022
·
4 min read
Genetown

Oxford Biomedica broadens leading viral vector offerings by incorporating Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the U.S. with Homology Medicines as 20% owner

Oxford Biomedica plc, a leading gene and cell therapy group, and Homology Medicines, Inc., a genetic medicines company, announced that the companies have agreed to establish a high-performing, full scope Adeno-Associated Virus Manufacturing and Innovation Business in the U.S.

January 28, 2022
·
14 min read
Philips and University Hospital Brandenburg an der Havel sign 10-year partnership to advance patient care

Royal Philips, a global leader in health technology, and the University Hospital Brandenburg an der Havel have signed a 10-year strategic partnership to renew and expand the hospital’s diagnostic and therapy options through the delivery of advanced technology solutions.

January 28, 2022
·
4 min read
Policy

Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced it has received clearance from the U.S. Food and Drug Administration for its Omnipod® 5 Automated Insulin Delivery System for individuals aged six years and older with type 1 diabetes.

January 28, 2022
·
6 min read
Business

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies.

January 28, 2022
·
18 min read